The United States Patent and Trademark Office (USPTO) has published patent application US20260079151A1, filed by the University of Notre Dame. The application details a novel three-dimensional immunomechanical organoid model for myeloid cells. This model is intended for basic research, high-throughput drug screening, and experiments in microgravity environments, facilitating the study of myeloid-mechanical interactions in various immunological and mechanical disease contexts.

This publication represents a new patent application and does not impose immediate compliance obligations. However, entities involved in drug development, biotechnology research, or the creation of laboratory models should be aware of this innovation. Companies developing or utilizing organoid models for research or drug screening may wish to review the patent application for potential intellectual property considerations or future licensing opportunities.